Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Warmack TS et al. – Overall, data supporting Beta–blockers as preferred therapy in hypertension are inadequate. Although most negative cardiovascular and cerebrovascular outcomes of beta–blockers were associated with atenolol therapy, data supporting other beta–blockers in hypertension are lacking.


Related Articles

Lessons in Hypertension from New Clinical Trials
Postgraduate Medicine, 11/24/09    Relevance Score: 94%

Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: Results from a phase II randomized, factorial, double-blind study of cediranib in patients with advanced solid tumors
Journal of Clinical Oncology, 11/13/09    Relevance Score: 94%

Decrease in FASN Expression in Adipose Tissue of Hypertensive Individuals
American Journal of Hypertension, 11/23/09    Relevance Score: 92%

Practical strategies for management of hypertension in the elderly
Internet Source, 10/13/09    Relevance Score: 92%

Hypertension treatment and management concerns in the elderly
Aging Health, 10/07/09    Relevance Score: 92%

Today in Cardiology...keeping you current

Beneficial Electrophysiological Effects of Trimetazidine in Patients With Postischemic Chronic Heart Failure
Journal of Cardiovascular Pharmacology and Therapeutics, 02/09/10

Role of Cardiac Magnetic Resonance Imaging in the Detection of Cardiac Amyloidosis
JACC - Journal of the American College of Cardiology: Cardiovascular Imaging, 02/09/10

Altered cholesterol and fatty acid metabolism in Huntington disease
Journal of Clinical Lipidology, 02/09/10

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address